Maryland
|
001-14494
|
33-0724736
|
||
(State or other jurisdiction
of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
10 North Park Place, Suite 201
Morristown, NJ
|
07960
|
|
(Address of principal executive offices)
|
(Zip Code)
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Nominee
|
Number of Votes For
|
Number of Votes Against
|
||
Douglas L. Drysdale
|
27,531,772
|
1,371,881
|
||
Steven A. Elms
|
24,183,759
|
4,719,894
|
||
Tasos G. Konidaris
|
26,863,398
|
2,040,255
|
||
John A. Sedor
|
25,051,343
|
3,852,310
|
Proposal
|
Number of Votes For
|
Number of VotesAgainst
|
Abstentions
|
|||
Approval of an Amendment to the Company’s Charter
|
26,325,203
|
2,506,304
|
72,145
|
Proposal
|
Number of Votes For
|
Number of VotesAgainst
|
Abstentions
|
|||
Approval of 2015 Omnibus Incentive Plan
|
21,415,574
|
7,465,409
|
22,669
|
Proposal
|
Number of Votes For
|
Number of VotesAgainst
|
Abstentions
|
|||
Approval, on an advisory basis, the Company’s executive compensation
|
21,212,319
|
7,586,800
|
104,533
|
Proposal
|
Number of Votes For
|
Number of VotesAgainst
|
Abstentions
|
|||
Ratification of Cherry Bekaert LLP
|
28,437,190
|
466,392
|
71,000
|
PERNIX THERAPEUTICS HOLDINGS, INC.
|
|||
Dated: June 22 2015
|
By:
|
/s/ Sanjay Patel
|
|
Sanjay Patel
|
|||
Chief Financial Officer
|